Jean-Marc Lalouel
10Patents
4h-index
9Co-inventors
49Inventor score
Filing activity: Sep 30, 1992 → Oct 16, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5374525A | Methods to determine predisposition to hypertension and association of variant angiotensinogen gene and hypertension | Emerging Cross-Sectional Technologies | 29 | Expired |
| US5763168A | Method to determine predisposition to hypertension | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5589584A | Angiotensinogen gene variants and predisposition to hypertension | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6153386A | Method to determine predisposition to hypertension | Chemistry; Metallurgy | 4 | Expired |
| US6165727A | Method to determine predisposition to hypertension | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5998145A | Method to determine predisposition to hypertension | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5529900A | Direct genetic test for glucocorticoid-remediable aldosteronism | Chemistry; Metallurgy | 0 | Expired |
| US7749725B2 | Drug screening and diagnosis based on paracrine tubular renin-angiotensin system | Emerging Cross-Sectional Technologies | 0 | Active |
| US6495338B1 | Drug screening and diagnosis based on paracrine tubular renin-angiotensin system | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6177252A | Method to determine predisposition to hypertension | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.